Doctor profile · Federal record
Dr. Rachael Cunnick, PA-C
Physician Assistant · Albuquerque, NM
- NPI 1972697753
- Accepts Medicare
- MIPS 93.3 / 100 · 2023
- 20 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
8300 Constitution Ave Ne, Pmg Endocrinology
Albuquerque, NM 87110
(505) 559-6400
fax (505) 559-6488 - Mailing address
-
Po Box 26666, Phs Provider Enrollment
Albuquerque, NM 871256666
Credentials & registration
- NPI registered
- October 2006 — 20 yrs on file
- Profile last updated
- September 23, 2025
- Year of graduation
- 2006 — 20 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State license (1)
- New Mexico #PA2006-0031
- Medicaid
- NM #62158520
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1972697753. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,636
Distinct HCPCS
8
Medicare allowed
$59,534
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 1,200 | 18 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 229 | 174 | $102 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 73 | 52 | $29 | |
99490 |
Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 37 | 14 | $51 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 31 | 29 | $72 | |
99443 |
Telephone medical discussion with physician, 21-30 minutes | 29 | 25 | $82 | |
96372 |
Injection of drug or substance under skin or into muscle | 25 | 19 | $11 | |
83036 |
Hemoglobin a1c level | 12 | 12 | $10 |
In context: peer comparison
Among 103 peers in this city , average services per provider: 77. This provider delivers 21× the peer median.Open Payments
Industry payments received
All-time total
$684
Transactions
32
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novo Nordisk Inc | 11 | $142.84 | |
| Phathom Pharmaceuticals, Inc. | 2 | $117.11 | |
| Lilly USA, LLC | 4 | $88.58 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $83.60 | |
| Mylan Specialty L.P. | 2 | $62.16 | |
| Abbott Laboratories | 3 | $54.79 | |
| Baxter Healthcare | 1 | $36.25 | |
| Otsuka America Pharmaceutical, Inc. | 2 | $33.83 | |
| ABBVIE INC. | 1 | $26.35 | |
| Xeris Pharmaceuticals, Inc. | 1 | $22.00 | |
| Amgen Inc. | 1 | $16.24 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,965
Patients
841
Total drug cost
$1,619,716
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 537 | 158 | $8,809 |
| Trulicity (Dulaglutide) | Brand | 400 | 72 | $520,500 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 299 | 83 | $243,233 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 236 | 78 | $4,580 |
| Atorvastatin Calcium | Generic | 211 | 75 | $3,378 |
| Metformin Hcl | Generic | 196 | 65 | $2,386 |
| Januvia (Sitagliptin Phosphate) | Brand | 150 | 33 | $140,416 |
| Jardiance (Empagliflozin) | Brand | 149 | 37 | $175,430 |
| Lisinopril | Generic | 149 | 50 | $1,377 |
| Novolog Flexpen (Insulin Aspart) | Brand | 137 | 35 | $200,468 |
Hospital affiliations
Frequently asked questions
What is Dr. Rachael Cunnick's medical specialty?
Dr. Rachael Cunnick practices Physician Assistant in Albuquerque, NM.
Where does Dr. Rachael Cunnick practice?
Dr. Rachael Cunnick practices at 8300 Constitution Ave Ne, Albuquerque, NM 87110. Office phone: 5055596400.
What is Dr. Rachael Cunnick's NPI?
Dr. Rachael Cunnick's National Provider Identifier (NPI) is 1972697753, issued by NPPES.
Does Dr. Rachael Cunnick accept Medicare assignment?
Yes. Dr. Rachael Cunnick accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Rachael Cunnick commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251). Source: CMS Medicare Physician & Other Practitioners file.